Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abide, Ablation, Academy, AccuCEA, adenocarcinoma, AGA, al, altogether, Anthem, Arizona, array, ARUP, ATA, attended, atypia, atypical, auditor, Avenue, awaiting, banking, Belgium, biased, bile, bioinformatic, Black, British, broadest, Canadian, catastrophe, cellular, Century, CEP, chemotherapy, Chicago, CHIP, chosen, Cigna, CIO, Columbia, commentary, composite, conclusion, Conference, conflicted, conflicting, constraint, converge, convergence, Corrupt, COSO, currency, cybersecurity, Dakota, database, DDW, delegating, Digestive, discovered, discreet, downgrade, Dr, drop, dropping, duct, ductal, efficacy, eighty, embedded, Epithelium, erosion, Evicore, FCPA, feature, Felice, fell, fingerprint, flooding, Fukuoka, GPO, GX, heterozygosity, Horizon, IDGGW, illiquid, incompliance, inoperable, insist, internationally, Iowa, Italy, Kalorama, Lake, Lane, Liberty, licensor, lieu, LOH, lung, MACRA, magazine, malware, marker, McCormick, menu, metastatic, Microdissection, miRInform®in, miRInform®thyroid, Mucosa, multinational, neoplastic, nonemployee, Northeastern, Notwithstanding, NYS, NYSE, official, offshore, ofNASDAQcontinued, ofthe, oldest, onNASDAQ, OnOctober, oral, Orlando, ourPathFinderTG®platform, outbreak, oversee, Oxford, PancreaSeq, PathFinderTG®platform, payer, PCAOB, PCR, PDAC, pharma, pipeline, political, portal, precursor, predictor, premier, pressure, Pretreated, profile, pronouncement, prove, proximity, PTEN, purview, Quadax, questioning, qui, Radiofrequency, rationally, Realty, Reauthorization, recalculated, recurrence, recurrent, Regenerated, repaid, repatriated, repatriation, repository, reproducibility, respridx, revaluation, revalued, Reveal, SAB, Salt, SEER, Sequenomholding, short, Spain, steal, Switzerland, tam, TCJA, terrorism, TERT, theMayodecision, TheTCJA, theWorldwide, ThyGenX®test, ThyraMIR®by, ThyraMIR®for, ThyraMIR®molecular, ThyraMIR®test, tool, top, TP, triennial, uncollectable, uncompleted, undistributed, uneconomical, uninsured, UnitedHealthcare, unrest, USCAP, Utah, Vancouver, Victoria, Wang, War, WCOG, weather, Wellmark, whistleblower, widespread, worldwide, worth
Removed:
acquiring, aggregated, allocate, announcing, ascertain, ascribed, attack, bad, bankruptcy, Cadillac, chairman, challenging, clause, climate, considerably, constitutionality, continuity, controlled, default, deliver, excluding, execute, exit, federally, headcount, highest, impeding, improper, light, marketable, Mio, negotiating, occasion, origination, play, premium, realigned, reissued, relation, reviewing, rollforward, routine, routinely, satisfied, Secretary, slower, sought, Spring, staggered, stay, sweeping, SWK, tangible, targeted, teaching, terminal, thirty, transferring, unclear, voluntarily, wrote
Filing tables
Filing exhibits
Related press release
IDXG similar filings
Filing view
External links
Exhibit 21.1
Interpace Diagnostics Group, Inc.
Subsidiaries
Interpace Diagnostics, LLC, a Delaware limited liability company, is a wholly-owned subsidiary of Interpace Diagnostics Group, Inc.
Interpace Diagnostics Corporation, a Delaware corporation, is a wholly-owned subsidiary of Interpace Diagnostics, LLC.
JS Genetics, Inc., a Delaware corporation, is a wholly-owned subsidiary of Interpace Diagnostics, LLC.